BioMarin Pharmaceutical Inc. (BMRN): A Bull Case Theory [Yahoo! Finance]
BioMarin Pharmaceutical (NASDAQ:BMRN) had its "market perform" rating reaffirmed by analysts at Leerink Partners. They now have a $60.00 price target on the stock, down previously from $82.00.
BioMarin Pharmaceutical (BMRN): Evaluating Valuation After Raised Guidance on Revenue Strength [Yahoo! Finance]
BioMarin Pharmaceutical (NASDAQ:BMRN) had its "sell (d)" rating reaffirmed by analysts at
Weiss Ratings.
2 Reasons to Like BMRN and 1 to Stay Skeptical [Yahoo! Finance]